Abbott Laboratories Quarterly Balance Sheets Chart
Quarterly
|
Annual
Abbott Laboratories Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 6,951,000,000 | 6,532,000,000 | 7,616,000,000 | 7,558,000,000 | 6,987,000,000 | 6,284,000,000 | 6,896,000,000 | 6,709,000,000 | 7,835,000,000 | 9,161,000,000 | 9,882,000,000 | 9,594,000,000 | 8,937,000,000 | 7,675,000,000 | 9,799,000,000 | 9,302,000,000 | 8,658,000,000 | 8,054,000,000 | 6,838,000,000 | 4,480,000,000 | 4,763,000,000 | 3,377,000,000 | 3,860,000,000 | 4,091,000,000 | 3,137,000,000 | 3,022,000,000 | 7,369,000,000 | 3,065,000,000 | 3,857,000,000 | 11,012,000,000 | 9,675,000,000 | 8,706,000,000 | 2,500,000,000 | 2,578,000,000 | 3,334,000,000 | 3,132,000,000 | 4,048,000,000 | 3,226,000,000 | 3,613,000,000 | 3,570,000,000 | 2,060,000,000 | 3,818,145,000 | 4,321,702,000 | 1,566,820,000 |
short-term investments | 331,000,000 | 312,000,000 | 230,000,000 | 232,000,000 | 367,000,000 | 338,000,000 | 320,000,000 | 371,000,000 | 313,000,000 | 353,000,000 | 483,000,000 | 390,000,000 | 286,000,000 | 318,000,000 | 251,000,000 | 274,000,000 | 291,000,000 | 244,000,000 | 239,000,000 | 239,000,000 | 181,000,000 | 199,000,000 | 185,000,000 | 187,000,000 | 160,000,000 | 154,000,000 | 2,007,000,000 | 1,860,000,000 | 623,000,000 | 3,007,000,000 | 7,129,000,000 | 6,623,000,000 | ||||||||||||
trade receivables, less allowances of 471 in 2025 and 439 in 2024 | 7,972,000,000 | |||||||||||||||||||||||||||||||||||||||||||
inventories: | ||||||||||||||||||||||||||||||||||||||||||||
finished products | 4,319,000,000 | 4,063,000,000 | 3,700,000,000 | 4,173,000,000 | 4,060,000,000 | 4,063,000,000 | 3,946,000,000 | 3,847,000,000 | 4,004,000,000 | 3,944,000,000 | 3,805,000,000 | 3,407,000,000 | 3,570,000,000 | 3,470,000,000 | 3,081,000,000 | 3,048,000,000 | 3,118,000,000 | 3,219,000,000 | 3,030,000,000 | 3,173,000,000 | 3,240,000,000 | 2,873,000,000 | 2,784,000,000 | 2,846,000,000 | 2,786,000,000 | 2,641,000,000 | 2,340,000,000 | 2,264,000,000 | 2,424,000,000 | 2,273,000,000 | 2,355,000,000 | 2,704,000,000 | 1,763,000,000 | 1,865,000,000 | 1,980,000,000 | 1,810,000,000 | 1,869,000,000 | 1,780,000,000 | 1,873,000,000 | 1,920,000,000 | 1,921,000,000 | 2,025,154,000 | 1,933,692,000 | 2,138,884,000 |
work in process | 962,000,000 | 890,000,000 | 840,000,000 | 877,000,000 | 880,000,000 | 881,000,000 | 807,000,000 | 888,000,000 | 845,000,000 | 805,000,000 | 680,000,000 | 726,000,000 | 710,000,000 | 695,000,000 | 694,000,000 | 710,000,000 | 796,000,000 | 773,000,000 | 712,000,000 | 721,000,000 | 675,000,000 | 615,000,000 | 560,000,000 | 584,000,000 | 584,000,000 | 536,000,000 | 561,000,000 | 563,000,000 | 536,000,000 | 456,000,000 | 450,000,000 | 509,000,000 | 326,000,000 | 340,000,000 | 306,000,000 | 289,000,000 | 303,000,000 | 287,000,000 | 290,000,000 | 339,000,000 | 322,000,000 | 705,676,000 | 724,835,000 | 746,890,000 |
materials | 1,673,000,000 | 1,686,000,000 | 1,654,000,000 | 1,763,000,000 | 1,874,000,000 | 1,883,000,000 | 1,817,000,000 | 1,915,000,000 | 2,022,000,000 | 1,924,000,000 | 1,688,000,000 | 1,601,000,000 | 1,619,000,000 | 1,526,000,000 | 1,382,000,000 | 1,503,000,000 | 1,525,000,000 | 1,395,000,000 | 1,270,000,000 | 1,258,000,000 | 1,287,000,000 | 1,080,000,000 | 972,000,000 | 962,000,000 | 982,000,000 | 908,000,000 | 880,000,000 | 887,000,000 | 866,000,000 | 754,000,000 | 798,000,000 | 782,000,000 | 524,000,000 | 608,000,000 | 500,000,000 | 534,000,000 | 563,000,000 | 556,000,000 | 533,000,000 | 564,000,000 | 532,000,000 | 577,928,000 | 510,114,000 | 525,147,000 |
total inventories | 6,954,000,000 | 6,639,000,000 | 6,194,000,000 | 6,813,000,000 | 6,814,000,000 | 6,827,000,000 | 6,570,000,000 | 6,650,000,000 | 6,871,000,000 | 6,673,000,000 | 6,173,000,000 | 5,734,000,000 | 5,899,000,000 | 5,691,000,000 | 5,157,000,000 | 5,261,000,000 | 5,439,000,000 | 5,387,000,000 | 5,012,000,000 | 5,152,000,000 | 5,202,000,000 | 4,568,000,000 | 4,316,000,000 | 4,392,000,000 | 4,352,000,000 | 4,085,000,000 | 3,781,000,000 | 3,714,000,000 | 3,826,000,000 | 3,483,000,000 | 3,603,000,000 | 3,995,000,000 | 2,613,000,000 | 2,813,000,000 | 2,786,000,000 | 2,633,000,000 | 2,735,000,000 | 2,623,000,000 | 2,696,000,000 | 2,823,000,000 | 2,775,000,000 | 3,308,758,000 | 3,168,641,000 | 3,410,921,000 |
prepaid expenses and other receivables | 2,260,000,000 | 2,343,000,000 | 2,150,000,000 | 2,232,000,000 | 2,293,000,000 | 2,468,000,000 | 2,307,000,000 | 2,152,000,000 | 2,796,000,000 | 2,568,000,000 | 2,401,000,000 | 2,134,000,000 | 2,131,000,000 | 1,962,000,000 | 1,858,000,000 | 1,842,000,000 | 1,970,000,000 | 1,942,000,000 | 1,919,000,000 | 1,718,000,000 | 1,582,000,000 | 1,935,000,000 | 1,720,000,000 | 1,895,000,000 | 1,912,000,000 | 1,964,000,000 | 1,986,000,000 | 2,104,000,000 | 2,157,000,000 | |||||||||||||||
total current assets | 24,468,000,000 | 23,153,000,000 | 23,656,000,000 | 23,802,000,000 | 23,119,000,000 | 22,376,000,000 | 22,670,000,000 | 22,664,000,000 | 23,505,000,000 | 24,377,000,000 | 25,224,000,000 | 24,845,000,000 | 24,956,000,000 | 23,429,000,000 | 24,239,000,000 | 23,492,000,000 | 22,627,000,000 | 21,817,000,000 | 20,441,000,000 | 17,390,000,000 | 17,221,000,000 | 15,498,000,000 | 15,667,000,000 | 16,119,000,000 | 15,195,000,000 | 14,409,000,000 | 18,196,000,000 | 14,122,000,000 | 14,964,000,000 | 21,377,000,000 | 19,983,000,000 | 19,329,000,000 | 12,978,000,000 | 12,988,000,000 | 12,406,000,000 | 15,894,000,000 | 21,131,000,000 | 19,985,000,000 | 16,464,000,000 | 18,258,000,000 | 17,931,000,000 | 19,447,420,000 | 19,915,307,000 | 17,690,678,000 |
investments | 958,000,000 | 907,000,000 | 886,000,000 | 912,000,000 | 877,000,000 | 818,000,000 | 799,000,000 | 788,000,000 | 799,000,000 | 776,000,000 | 766,000,000 | 764,000,000 | 734,000,000 | 763,000,000 | 816,000,000 | 812,000,000 | 805,000,000 | 832,000,000 | 821,000,000 | 803,000,000 | 776,000,000 | 790,000,000 | 883,000,000 | 874,000,000 | 851,000,000 | 867,000,000 | 971,000,000 | 940,000,000 | 913,000,000 | 1,386,000,000 | 1,545,000,000 | 1,756,000,000 | 2,997,000,000 | 3,339,000,000 | 3,552,000,000 | 3,055,000,000 | 243,000,000 | 244,000,000 | 221,000,000 | 130,000,000 | 122,000,000 | 255,153,000 | 251,240,000 | 1,120,483,000 |
property and equipment, at cost | 24,472,000,000 | 23,418,000,000 | 22,857,000,000 | 22,061,000,000 | 22,055,000,000 | 21,111,000,000 | 20,926,000,000 | 20,605,000,000 | 19,306,000,000 | 19,458,000,000 | 19,521,000,000 | 19,182,000,000 | 19,074,000,000 | 18,697,000,000 | 17,972,000,000 | 17,374,000,000 | 16,707,000,000 | 16,343,000,000 | 16,331,000,000 | 15,905,000,000 | 15,520,000,000 | 15,309,000,000 | 15,556,000,000 | 14,698,000,000 | 14,476,000,000 | 14,172,000,000 | 12,452,000,000 | 12,712,000,000 | 12,709,000,000 | 12,528,000,000 | 12,433,000,000 | 12,251,000,000 | 12,694,000,000 | 13,096,000,000 | 13,005,000,000 | 17,259,216,000 | 16,856,968,000 | 16,803,187,000 | ||||||
less: accumulated depreciation and amortization | 13,077,000,000 | 12,486,000,000 | 12,082,000,000 | 12,236,000,000 | 11,828,000,000 | 11,948,000,000 | 11,779,000,000 | 11,559,000,000 | 11,477,000,000 | 11,323,000,000 | 11,050,000,000 | 10,617,000,000 | 10,640,000,000 | 10,613,000,000 | 10,405,000,000 | 10,351,000,000 | 10,258,000,000 | 9,865,000,000 | 9,764,000,000 | 9,352,000,000 | 9,031,000,000 | 8,800,000,000 | 8,761,000,000 | 8,518,000,000 | 8,506,000,000 | 8,279,000,000 | 8,072,000,000 | 7,877,000,000 | 7,897,000,000 | 7,479,000,000 | 7,190,000,000 | 6,907,000,000 | 6,718,000,000 | 6,886,000,000 | 6,873,000,000 | 6,731,000,000 | 6,695,000,000 | 6,552,000,000 | 6,822,000,000 | 7,161,000,000 | 7,057,000,000 | 9,319,429,000 | 8,981,360,000 | 8,743,073,000 |
net property and equipment | 11,395,000,000 | 10,932,000,000 | 10,658,000,000 | 10,621,000,000 | 10,233,000,000 | 10,107,000,000 | 10,154,000,000 | 9,552,000,000 | 9,449,000,000 | 9,282,000,000 | 9,162,000,000 | 8,689,000,000 | 8,818,000,000 | 8,908,000,000 | 8,959,000,000 | 8,831,000,000 | 8,816,000,000 | 8,832,000,000 | 9,029,000,000 | 8,620,000,000 | 8,343,000,000 | 7,907,000,000 | 8,038,000,000 | 7,825,000,000 | 7,825,000,000 | 7,626,000,000 | 7,448,000,000 | 7,432,000,000 | 7,659,000,000 | 7,219,000,000 | 7,286,000,000 | 7,265,000,000 | 5,734,000,000 | 5,826,000,000 | 5,836,000,000 | 5,797,000,000 | 5,738,000,000 | 5,699,000,000 | 5,872,000,000 | 5,935,000,000 | 5,948,000,000 | 7,939,787,000 | 7,875,608,000 | 8,060,114,000 |
intangible assets, net of amortization | 5,920,000,000 | 6,261,000,000 | 6,647,000,000 | 7,352,000,000 | 7,827,000,000 | 8,296,000,000 | 8,815,000,000 | 9,282,000,000 | 9,834,000,000 | 10,006,000,000 | 10,454,000,000 | 10,850,000,000 | 11,592,000,000 | 12,225,000,000 | 12,739,000,000 | 13,312,000,000 | 13,681,000,000 | 14,181,000,000 | 14,784,000,000 | 15,208,000,000 | 15,783,000,000 | 16,265,000,000 | 17,025,000,000 | 17,465,000,000 | 18,091,000,000 | 18,472,000,000 | 19,477,000,000 | 19,951,000,000 | 20,943,000,000 | 18,578,000,000 | 18,653,000,000 | 19,405,000,000 | 4,674,000,000 | 5,311,000,000 | 5,458,000,000 | 5,844,000,000 | 5,785,000,000 | 5,979,000,000 | 6,094,000,000 | 5,428,000,000 | 5,613,000,000 | 12,646,677,000 | 10,266,399,000 | 10,663,369,000 |
goodwill | 23,952,000,000 | 23,359,000,000 | 23,108,000,000 | 23,658,000,000 | 23,308,000,000 | 23,383,000,000 | 23,679,000,000 | 23,277,000,000 | 23,258,000,000 | 22,927,000,000 | 22,799,000,000 | 22,284,000,000 | 22,744,000,000 | 23,179,000,000 | 23,231,000,000 | 23,299,000,000 | 23,485,000,000 | 23,384,000,000 | 23,744,000,000 | 23,338,000,000 | 23,082,000,000 | 22,927,000,000 | 23,195,000,000 | 23,046,000,000 | 23,329,000,000 | 23,209,000,000 | 23,416,000,000 | 23,844,000,000 | 24,227,000,000 | 22,066,000,000 | 22,132,000,000 | 21,353,000,000 | 7,812,000,000 | 9,752,000,000 | 9,775,000,000 | 9,750,000,000 | 9,896,000,000 | 9,855,000,000 | 10,048,000,000 | 9,751,000,000 | 9,781,000,000 | 15,807,536,000 | 14,218,098,000 | 15,007,686,000 |
deferred income taxes and other assets | 17,306,000,000 | 16,836,000,000 | 16,459,000,000 | 8,011,000,000 | 7,653,000,000 | 7,487,000,000 | 7,097,000,000 | 6,527,000,000 | 6,509,000,000 | 6,426,000,000 | 6,033,000,000 | 5,369,000,000 | 5,358,000,000 | 5,503,000,000 | 5,212,000,000 | 4,049,000,000 | 3,855,000,000 | 3,739,000,000 | 3,729,000,000 | 3,684,000,000 | 3,571,000,000 | 3,390,000,000 | 3,079,000,000 | 3,210,000,000 | 3,136,000,000 | 3,027,000,000 | 2,110,000,000 | 2,005,000,000 | 2,082,000,000 | 1,565,000,000 | 1,552,000,000 | 1,779,000,000 | 2,523,000,000 | 2,613,000,000 | 2,608,000,000 | 1,383,000,000 | 1,330,000,000 | 1,330,000,000 | 1,772,000,000 | 1,921,000,000 | 2,214,000,000 | 1,277,047,000 | 854,750,000 | 816,292,000 |
liabilities and shareholders’ investment | ||||||||||||||||||||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||||||||||||||||||||
trade accounts payable | 4,306,000,000 | 4,214,000,000 | 4,195,000,000 | 4,034,000,000 | 4,125,000,000 | 4,178,000,000 | 4,295,000,000 | 3,961,000,000 | 4,211,000,000 | 4,167,000,000 | 4,607,000,000 | 4,133,000,000 | 4,493,000,000 | 4,757,000,000 | 4,408,000,000 | 4,017,000,000 | 4,017,000,000 | 4,066,000,000 | 3,946,000,000 | 3,189,000,000 | 3,335,000,000 | 3,181,000,000 | 3,252,000,000 | 3,029,000,000 | 3,222,000,000 | 3,045,000,000 | 2,730,000,000 | 2,503,000,000 | 2,476,000,000 | 1,858,000,000 | 1,667,000,000 | 1,481,000,000 | 1,051,000,000 | 1,153,000,000 | 1,053,000,000 | 1,007,000,000 | 1,000,000,000 | 1,012,000,000 | 965,000,000 | 1,062,000,000 | 1,074,000,000 | 1,531,720,000 | 1,615,606,000 | 1,663,523,000 |
salaries, wages and commissions | 1,550,000,000 | 1,167,000,000 | 1,701,000,000 | 1,618,000,000 | 1,389,000,000 | 1,092,000,000 | 1,597,000,000 | 1,479,000,000 | 1,362,000,000 | 1,098,000,000 | 1,556,000,000 | 1,426,000,000 | 1,315,000,000 | 1,147,000,000 | 1,625,000,000 | 1,470,000,000 | 1,248,000,000 | 1,117,000,000 | 1,416,000,000 | 1,439,000,000 | 1,121,000,000 | 949,000,000 | 1,237,000,000 | 1,258,000,000 | 1,018,000,000 | 886,000,000 | 1,241,000,000 | 1,034,000,000 | 949,000,000 | 1,103,000,000 | 905,000,000 | 802,000,000 | 799,000,000 | 717,000,000 | 606,000,000 | 854,000,000 | 759,000,000 | 649,000,000 | 867,000,000 | 828,000,000 | 681,000,000 | |||
other accrued liabilities | 5,656,000,000 | 5,600,000,000 | 5,143,000,000 | 5,427,000,000 | 5,071,000,000 | 5,220,000,000 | 5,422,000,000 | 5,347,000,000 | 5,334,000,000 | 5,758,000,000 | 5,845,000,000 | 5,475,000,000 | 5,400,000,000 | 5,577,000,000 | 5,181,000,000 | 5,264,000,000 | 5,354,000,000 | 5,247,000,000 | 5,165,000,000 | 4,659,000,000 | 4,206,000,000 | 4,408,000,000 | 4,035,000,000 | 4,112,000,000 | 3,961,000,000 | 4,130,000,000 | 3,807,000,000 | 3,887,000,000 | 4,144,000,000 | 3,617,000,000 | 3,357,000,000 | 3,506,000,000 | 2,715,000,000 | 2,931,000,000 | 3,118,000,000 | 3,294,000,000 | 3,288,000,000 | 3,380,000,000 | 2,875,000,000 | 3,247,000,000 | 3,401,000,000 | 5,677,368,000 | ||
dividends payable | 1,030,000,000 | 1,032,000,000 | 1,024,000,000 | 956,000,000 | 959,000,000 | 959,000,000 | 955,000,000 | 886,000,000 | 886,000,000 | 888,000,000 | 887,000,000 | 820,000,000 | 824,000,000 | 824,000,000 | 831,000,000 | 797,000,000 | 799,000,000 | 801,000,000 | 798,000,000 | 639,000,000 | 637,000,000 | 637,000,000 | 635,000,000 | 567,000,000 | 566,000,000 | 566,000,000 | 493,000,000 | 492,000,000 | 492,000,000 | 462,000,000 | 461,000,000 | 461,000,000 | 384,000,000 | 383,000,000 | 382,000,000 | 359,000,000 | 358,000,000 | 358,000,000 | 332,000,000 | 331,000,000 | 331,000,000 | |||
income taxes payable | 390,000,000 | 485,000,000 | 594,000,000 | 713,000,000 | 601,000,000 | 562,000,000 | 492,000,000 | 318,000,000 | 273,000,000 | 334,000,000 | 343,000,000 | 394,000,000 | 355,000,000 | 338,000,000 | 306,000,000 | 368,000,000 | 242,000,000 | 276,000,000 | 362,000,000 | 117,000,000 | 165,000,000 | 165,000,000 | 226,000,000 | 67,000,000 | 83,000,000 | 277,000,000 | 231,000,000 | 188,000,000 | 212,000,000 | 180,000,000 | 192,000,000 | 186,000,000 | 240,000,000 | 232,000,000 | 261,000,000 | 483,000,000 | 589,000,000 | 534,000,000 | 481,000,000 | 181,000,000 | 152,000,000 | 874,915,000 | 906,674,000 | 769,488,000 |
current portion of long-term debt | 507,000,000 | 506,000,000 | 1,500,000,000 | 2,154,000,000 | 1,615,000,000 | 2,010,000,000 | 1,080,000,000 | 1,051,000,000 | 2,284,000,000 | 2,285,000,000 | 2,251,000,000 | 1,117,000,000 | 5,000,000 | 4,000,000 | 754,000,000 | 754,000,000 | 755,000,000 | 756,000,000 | 7,000,000 | 6,000,000 | 1,290,000,000 | 1,264,000,000 | 1,277,000,000 | 1,254,000,000 | 8,000,000 | 8,000,000 | 4,063,000,000 | 506,000,000 | 507,000,000 | 504,000,000 | 3,000,000 | 3,000,000 | 4,000,000 | 4,000,000 | 3,000,000 | 32,000,000 | 32,000,000 | 51,000,000 | 206,000,000 | 9,000,000 | 8,000,000 | 2,218,542,000 | 2,217,419,000 | 718,093,000 |
total current liabilities | 13,439,000,000 | 13,004,000,000 | 14,157,000,000 | 14,902,000,000 | 13,760,000,000 | 14,021,000,000 | 13,841,000,000 | 13,042,000,000 | 14,350,000,000 | 14,530,000,000 | 15,489,000,000 | 13,365,000,000 | 12,392,000,000 | 12,647,000,000 | 13,105,000,000 | 12,867,000,000 | 12,614,000,000 | 12,462,000,000 | 11,907,000,000 | 10,257,000,000 | 10,959,000,000 | 10,808,000,000 | 10,863,000,000 | 10,491,000,000 | 9,062,000,000 | 9,113,000,000 | 12,776,000,000 | 8,951,000,000 | 9,010,000,000 | 7,935,000,000 | 6,803,000,000 | 6,646,000,000 | 8,321,000,000 | 8,673,000,000 | 8,393,000,000 | 8,755,000,000 | 9,185,000,000 | 9,206,000,000 | 10,823,000,000 | 9,853,000,000 | 10,186,000,000 | 15,583,871,000 | 14,689,260,000 | 15,183,485,000 |
long-term debt | 12,930,000,000 | 12,736,000,000 | 12,625,000,000 | 12,825,000,000 | 13,139,000,000 | 12,576,000,000 | 13,599,000,000 | 14,477,000,000 | 14,562,000,000 | 14,615,000,000 | 14,522,000,000 | 15,297,000,000 | 16,755,000,000 | 17,086,000,000 | 17,296,000,000 | 17,446,000,000 | 17,547,000,000 | 17,489,000,000 | 18,527,000,000 | 18,349,000,000 | 18,184,000,000 | 16,804,000,000 | 16,661,000,000 | 17,639,000,000 | 18,982,000,000 | 18,845,000,000 | 19,284,000,000 | 19,823,000,000 | 21,154,000,000 | 23,310,000,000 | 23,810,000,000 | 23,764,000,000 | 5,975,000,000 | 6,016,000,000 | 5,977,000,000 | 5,953,000,000 | 5,862,000,000 | 5,931,000,000 | 3,719,000,000 | 3,403,000,000 | 3,387,000,000 | 12,910,681,000 | 12,612,655,000 | 10,878,649,000 |
post-employment obligations, deferred income taxes and other long-term liabilities | 6,801,000,000 | 6,644,000,000 | 6,601,000,000 | 6,558,000,000 | 6,827,000,000 | 6,877,000,000 | 7,038,000,000 | 7,417,000,000 | 8,255,000,000 | 8,339,000,000 | 8,645,000,000 | 8,844,000,000 | 9,079,000,000 | 9,046,000,000 | 8,842,000,000 | 8,835,000,000 | 8,738,000,000 | 8,390,000,000 | 8,489,000,000 | 8,523,000,000 | 8,679,000,000 | 8,867,000,000 | 9,143,000,000 | 8,785,000,000 | 8,750,000,000 | 8,930,000,000 | 4,245,000,000 | 4,347,000,000 | 4,425,000,000 | 5,798,000,000 | 5,952,000,000 | 5,970,000,000 | 4,883,000,000 | 4,514,000,000 | 4,599,000,000 | 6,284,148,000 | ||||||||
commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||
shareholders’ investment: | ||||||||||||||||||||||||||||||||||||||||||||
preferred shares, one dollar par value authorized — 1,000,000 shares, none issued | ||||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2025: 1,996,448,469; 2024: 1,991,472,630 | 25,284,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2025: 255,988,730; 2024: 259,774,639 | -16,610,000,000 | |||||||||||||||||||||||||||||||||||||||||||
earnings employed in the business | 48,467,000,000 | 47,715,000,000 | 47,261,000,000 | 39,056,000,000 | 38,354,000,000 | 38,011,000,000 | 37,554,000,000 | 36,920,000,000 | 36,355,000,000 | 35,868,000,000 | 35,257,000,000 | 35,115,000,000 | 34,487,000,000 | 33,295,000,000 | 31,528,000,000 | 30,376,000,000 | 29,053,000,000 | 28,669,000,000 | 27,627,000,000 | 26,266,000,000 | 25,669,000,000 | 25,786,000,000 | 25,847,000,000 | 25,440,000,000 | 25,045,000,000 | 24,613,000,000 | 24,144,000,000 | 24,080,000,000 | 23,856,000,000 | 25,320,000,000 | 25,202,000,000 | 25,387,000,000 | 25,162,000,000 | 25,884,000,000 | 25,654,000,000 | 25,375,000,000 | 25,162,000,000 | 24,740,000,000 | 22,335,000,000 | 22,137,000,000 | 22,005,000,000 | 18,181,133,000 | 17,978,462,000 | 17,367,857,000 |
accumulated other comprehensive income | -6,576,000,000 | -7,417,000,000 | -7,906,000,000 | -7,804,000,000 | -8,135,000,000 | -8,166,000,000 | -7,839,000,000 | -8,480,000,000 | -8,071,000,000 | -8,039,000,000 | -8,051,000,000 | -9,445,000,000 | -8,706,000,000 | -8,474,000,000 | -8,374,000,000 | -9,240,000,000 | -9,066,000,000 | -9,285,000,000 | -8,946,000,000 | -9,044,000,000 | -9,080,000,000 | -9,386,000,000 | -8,465,000,000 | -7,763,000,000 | -7,365,000,000 | |||||||||||||||||||
total abbott shareholders’ investment | 50,565,000,000 | 48,811,000,000 | 47,664,000,000 | 39,796,000,000 | 39,318,000,000 | 38,810,000,000 | 38,603,000,000 | 37,481,000,000 | 37,174,000,000 | 37,010,000,000 | 36,686,000,000 | 35,675,000,000 | 36,490,000,000 | 35,399,000,000 | 35,802,000,000 | 34,422,000,000 | 33,800,000,000 | 33,562,000,000 | 32,784,000,000 | 31,386,000,000 | 30,578,000,000 | 30,218,000,000 | 31,088,000,000 | 31,817,000,000 | 31,686,000,000 | 30,925,000,000 | 30,705,000,000 | 30,577,000,000 | 31,399,000,000 | 32,032,000,000 | 31,602,000,000 | 31,362,000,000 | 20,776,000,000 | 20,675,000,000 | 20,722,000,000 | 21,111,000,000 | 23,008,000,000 | 21,874,000,000 | 22,888,000,000 | 23,602,000,000 | 23,390,000,000 | 21,403,932,000 | 19,911,709,000 | 20,860,099,000 |
noncontrolling interests in subsidiaries | 264,000,000 | 253,000,000 | 237,000,000 | 232,000,000 | 242,000,000 | 233,000,000 | 224,000,000 | 213,000,000 | 230,000,000 | 222,000,000 | 219,000,000 | 209,000,000 | 226,000,000 | 230,000,000 | 222,000,000 | 216,000,000 | 229,000,000 | 226,000,000 | 219,000,000 | 209,000,000 | 220,000,000 | 209,000,000 | 213,000,000 | 202,000,000 | 208,000,000 | 204,000,000 | 193,000,000 | 197,000,000 | 202,000,000 | 186,000,000 | 186,000,000 | 185,000,000 | 120,000,000 | 120,000,000 | 120,000,000 | 108,000,000 | 118,000,000 | 114,000,000 | 105,000,000 | 102,000,000 | 99,000,000 | 78,792,000 | 82,925,000 | 152,241,000 |
total shareholders’ investment | 50,829,000,000 | 49,064,000,000 | 47,901,000,000 | 40,028,000,000 | 39,560,000,000 | 39,043,000,000 | 38,827,000,000 | 37,694,000,000 | 37,404,000,000 | 37,232,000,000 | 36,905,000,000 | 35,884,000,000 | 36,716,000,000 | 35,629,000,000 | 36,024,000,000 | 34,638,000,000 | 34,029,000,000 | 33,788,000,000 | 33,003,000,000 | 31,595,000,000 | 30,798,000,000 | 30,427,000,000 | 31,301,000,000 | 32,019,000,000 | 31,894,000,000 | 31,129,000,000 | 30,898,000,000 | 30,774,000,000 | 31,601,000,000 | 32,218,000,000 | 31,788,000,000 | 31,547,000,000 | 20,896,000,000 | 20,795,000,000 | 20,842,000,000 | 21,219,000,000 | 23,126,000,000 | 21,988,000,000 | 22,993,000,000 | 23,704,000,000 | 23,489,000,000 | |||
trade receivables, less allowances of 449 in 2025 and 439 in 2024 | 7,327,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2025: 1,995,858,606; 2024: 1,991,472,630 | 25,125,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2025: 256,021,416; 2024: 259,774,639 | -16,612,000,000 | |||||||||||||||||||||||||||||||||||||||||||
investments, primarily bank time deposits and u.s. treasury bills | 351,000,000 | 383,000,000 | 288,000,000 | 450,000,000 | 310,000,000 | 280,000,000 | 1,264,000,000 | 3,492,000,000 | 4,987,000,000 | |||||||||||||||||||||||||||||||||||
trade receivables, less allowances of — 2024: 439; 2023: 444 | 6,925,000,000 | |||||||||||||||||||||||||||||||||||||||||||
other prepaid expenses and receivables | 2,570,000,000 | 2,256,000,000 | 2,663,000,000 | 2,346,000,000 | 1,867,000,000 | 1,786,000,000 | ||||||||||||||||||||||||||||||||||||||
property and equipment, at cost: | ||||||||||||||||||||||||||||||||||||||||||||
land | 528,000,000 | 529,000,000 | 511,000,000 | 525,000,000 | 538,000,000 | 519,000,000 | ||||||||||||||||||||||||||||||||||||||
buildings | 4,207,000,000 | 4,161,000,000 | 4,053,000,000 | 4,007,000,000 | 4,014,000,000 | 3,702,000,000 | ||||||||||||||||||||||||||||||||||||||
equipment | 15,517,000,000 | 15,179,000,000 | 14,164,000,000 | 13,528,000,000 | 12,884,000,000 | 11,468,000,000 | ||||||||||||||||||||||||||||||||||||||
construction in progress | 2,488,000,000 | 2,064,000,000 | 1,484,000,000 | 1,304,000,000 | 1,357,000,000 | 1,110,000,000 | ||||||||||||||||||||||||||||||||||||||
post-employment obligations and other long-term liabilities | 6,731,000,000 | 6,947,000,000 | 7,522,000,000 | 8,771,000,000 | 9,111,000,000 | 9,062,000,000 | 7,396,344,000 | 6,084,853,000 | ||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,991,472,630; 2023: 1,987,883,852 | 25,153,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2024: 259,774,639; 2023: 253,807,494 | -16,844,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 456 in 2024 and 444 in 2023 | 7,051,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,991,051,414; 2023: 1,987,883,852 | 25,020,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2024: 256,595,476; 2023: 253,807,494 | -16,476,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 441 in 2024 and 444 in 2023 | 6,854,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,990,029,292; 2023: 1,987,883,852 | 24,858,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2024: 250,131,563; 2023: 253,807,494 | -15,759,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 439 in 2024 and 444 in 2023 | 6,605,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,989,789,999; 2023: 1,987,883,852 | 24,726,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2024: 250,155,515; 2023: 253,807,494 | -15,761,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of — 2023: 444; 2022: 500 | 6,565,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,987,883,852; 2022: 1,986,519,278 | 24,869,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2023: 253,807,494; 2022: 248,724,257 | -15,981,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 472 in 2023 and 500 in 2022 | 6,499,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,987,305,154; 2022: 1,986,519,278 | 24,727,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2023: 251,246,618; 2022: 248,724,257 | -15,686,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 485 in 2023 and 500 in 2022 | 6,172,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,987,181,491; 2022: 1,986,519,278 | 24,612,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2023: 251,823,511; 2022: 248,724,257 | -15,722,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 503 in 2023 and 500 in 2022 | 6,020,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,986,904,170; 2022: 1,986,519,278 | 24,488,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2023: 247,957,371; 2022: 248,724,257 | -15,307,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of — 2022: 500; 2021: 519 | 6,218,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,986,519,278; 2021: 1,985,273,421 | 24,709,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2022: 248,724,257; 2021: 221,191,228 | -15,229,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 520 in 2022 and 519 in 2021 | 6,408,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,985,919,440; 2021: 1,985,273,421 | 24,560,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2022: 242,345,663; 2021: 221,191,228 | -14,555,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 572 in 2022 and 519 in 2021 | 7,199,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,985,676,735; 2021: 1,985,273,421 | 24,429,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2022: 234,456,992; 2021: 221,191,228 | -13,720,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 640 in 2022 and 519 in 2021 | 7,179,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| 74,007,000,000 | 19,364,000,000 | 73,795,000,000 | 73,269,000,000 | 72,785,000,000 | 18,793,000,000 | 69,043,000,000 | 68,776,000,000 | 66,777,000,000 | 16,799,000,000 | 68,539,000,000 | 68,427,000,000 | ||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,985,525,053; 2021: 1,985,273,421 | 24,304,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2022: 234,582,764; 2021: 221,191,228 | -13,726,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of - 2021: 519; 2020: 460 | 6,487,000,000 | |||||||||||||||||||||||||||||||||||||||||||
short-term borrowings | 197,000,000 | 199,000,000 | 199,000,000 | 213,000,000 | 208,000,000 | 205,000,000 | 204,000,000 | 201,000,000 | 204,000,000 | 204,000,000 | 201,000,000 | 211,000,000 | 341,000,000 | 230,000,000 | 211,000,000 | 218,000,000 | 207,000,000 | 2,531,000,000 | 2,892,000,000 | 2,610,000,000 | 2,370,000,000 | 2,867,000,000 | 2,921,000,000 | 4,376,000,000 | 3,953,000,000 | 4,370,000,000 | 3,587,830,000 | 3,650,975,000 | 5,730,427,000 | |||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,985,273,421; 2020: 1,981,156,896 | 24,470,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2021: 221,191,228; 2020: 209,926,622 | -11,822,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 507 in 2021 and 460 in 2020 | 6,405,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,983,103,854; 2020: 1,981,156,896 | 24,285,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2021: 214,816,885; 2020: 209,926,622 | -10,999,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 498 in 2021 and 460 in 2020 | 6,113,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,982,553,488; 2020: 1,981,156,896 | 24,153,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2021: 209,736,139; 2020: 209,926,622 | -10,340,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 475 in 2021 and 460 in 2020 | 6,096,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,982,205,491; 2020: 1,981,156,896 | 24,023,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2021: 205,385,343; 2020: 209,926,622 | -9,845,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of — 2020: 460; 2019: 384 | 6,414,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,981,156,896; 2019: 1,976,855,085 | 24,145,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2020: 209,926,622; 2019: 214,351,838 | -10,042,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 446 in 2020 and 384 in 2019 | 5,649,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,980,767,223; 2019: 1,976,855,085 | 24,037,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2020: 208,405,642; 2019: 214,351,838 | -9,873,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 422 in 2020 and 384 in 2019 | 5,140,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,979,594,379; 2019: 1,976,855,085 | 23,893,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2020: 209,064,380; 2019: 214,351,838 | -9,904,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 389 in 2020 and 384 in 2019 | 5,292,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,978,112,501 ; 2019: 1,976,855,085 | 23,731,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2020: 209,267,175 ; 2019: 214,351,838 | -9,913,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of — 2019: 384; 2018: 314 | 5,425,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2019: 1,976,855,085; 2018: 1,971,189,465 | 23,853,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2019: 214,351,838; 2018: 215,570,043 | -10,147,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 354 in 2019 and 314 in 2018 | 5,450,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2019: 1,976,705,285; 2018: 1,971,189,465 | 23,771,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2019: 208,249,580; 2018: 215,570,043 | -9,631,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 338 in 2019 and 314 in 2018 | 5,548,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount - shares: 2019: 1,976,248,129 ; 2018: 1,971,189,465 | 23,665,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2019: 208,850,514 ; 2018: 215,570,043 | -9,659,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 331 in 2019 and 314 in 2018 | 5,345,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2019: 1,973,472,506; 2018: 1,971,189,465 | 23,461,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2019: 209,291,244; 2018: 215,570,043 | ||||||||||||||||||||||||||||||||||||||||||||
common shares: | ||||||||||||||||||||||||||||||||||||||||||||
balance at january 1 | 24,560,000,000 | |||||||||||||||||||||||||||||||||||||||||||
shares: 2019: 1,971,189,465; 2018: 1,965,908,188 | 23,512,000,000 | |||||||||||||||||||||||||||||||||||||||||||
issued under incentive stock programs | ||||||||||||||||||||||||||||||||||||||||||||
shares: 2019: 2,283,041; 2018: 3,422,819 | 76,000,000 | |||||||||||||||||||||||||||||||||||||||||||
share-based compensation | 237,000,000 | 396,000,000 | 313,000,000 | 212,000,000 | 338,000,000 | 263,000,000 | 171,000,000 | 263,000,000 | 214,000,000 | 152,000,000 | 249,000,000 | 205,000,000 | 148,000,000 | 208,000,000 | 168,000,000 | 119,000,000 | ||||||||||||||||||||||||||||
issuance of restricted stock awards | ||||||||||||||||||||||||||||||||||||||||||||
balance at march 31 | 24,613,000,000 | |||||||||||||||||||||||||||||||||||||||||||
shares: 2019: 1,973,472,506; 2018: 1,969,331,007 | 23,461,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury: | ||||||||||||||||||||||||||||||||||||||||||||
shares: 2019: 215,570,043; 2018: 222,305,719 | -9,962,000,000 | |||||||||||||||||||||||||||||||||||||||||||
shares: 2019: 6,544,927; 2018: 6,402,695 | 303,000,000 | |||||||||||||||||||||||||||||||||||||||||||
purchased | ||||||||||||||||||||||||||||||||||||||||||||
shares: 2019: 266,128; 2018: 240,217 | ||||||||||||||||||||||||||||||||||||||||||||
shares: 2019: 209,291,244; 2018: 216,143,241 | -9,679,000,000 | |||||||||||||||||||||||||||||||||||||||||||
earnings employed in the business: | ||||||||||||||||||||||||||||||||||||||||||||
impact of adoption of new accounting standards | ||||||||||||||||||||||||||||||||||||||||||||
net earnings | 672,000,000 | 1,714,000,000 | 1,151,000,000 | 418,000,000 | 1,305,000,000 | 702,000,000 | 419,000,000 | 602,000,000 | 931,000,000 | 316,000,000 | 3,656,000,000 | 3,076,000,000 | 2,292,000,000 | 1,380,000,000 | 841,000,000 | 375,000,000 | ||||||||||||||||||||||||||||
cash dividends declared on common shares | ||||||||||||||||||||||||||||||||||||||||||||
effect of common and treasury share transactions | ||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income: | ||||||||||||||||||||||||||||||||||||||||||||
impact of adoption of new accounting standard | ||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income | 116,000,000 | |||||||||||||||||||||||||||||||||||||||||||
noncontrolling interests in subsidiaries: | ||||||||||||||||||||||||||||||||||||||||||||
noncontrolling interests’ share of income, business combinations, net of distributions and share repurchases | 6,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 326 in 2018 and 294 in 2017 | 5,271,000,000 | |||||||||||||||||||||||||||||||||||||||||||
current assets held for disposition | 12,000,000 | 17,000,000 | 20,000,000 | 552,000,000 | 66,000,000 | 76,000,000 | 139,000,000 | 93,000,000 | 173,000,000 | 1,100,000,000 | 252,000,000 | 249,000,000 | ||||||||||||||||||||||||||||||||
non-current assets held for disposition | 19,000,000 | 121,000,000 | 120,000,000 | 57,000,000 | 2,779,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 3,000,000 | 2,043,000,000 | 52,000,000 | 53,000,000 | |||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2018: 1,970,590,472; 2017: 1,965,908,188 | 23,428,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2018: 214,257,440; 2017: 222,305,719 | ||||||||||||||||||||||||||||||||||||||||||||
cash flow from (used in) operating activities: | ||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net earnings to net cash from operating activities - | ||||||||||||||||||||||||||||||||||||||||||||
depreciation | 825,000,000 | 556,000,000 | 268,000,000 | 763,000,000 | 508,000,000 | 252,000,000 | 605,000,000 | 405,000,000 | 203,000,000 | 648,000,000 | 416,000,000 | 215,000,000 | 689,000,000 | 463,000,000 | 224,000,000 | |||||||||||||||||||||||||||||
amortization of intangible assets | 1,690,000,000 | 1,146,000,000 | 584,000,000 | 1,415,000,000 | 914,000,000 | 522,000,000 | 429,000,000 | 289,000,000 | 144,000,000 | |||||||||||||||||||||||||||||||||||
amortization of inventory step-up | 32,000,000 | 32,000,000 | 32,000,000 | 840,000,000 | 822,000,000 | 392,000,000 | ||||||||||||||||||||||||||||||||||||||
gain on sale of businesses | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables | 30,000,000 | 82,000,000 | ||||||||||||||||||||||||||||||||||||||||||
inventories | 39,000,000 | |||||||||||||||||||||||||||||||||||||||||||
other | 608,000,000 | 30,000,000 | 42,000,000 | 562,000,000 | 50,000,000 | 101,000,000 | 34,000,000 | 28,000,000 | 535,000,000 | 301,000,000 | 230,000,000 | 72,000,000 | 27,000,000 | 27,000,000 | ||||||||||||||||||||||||||||||
net cash from operating activities | 4,535,000,000 | 2,352,000,000 | 1,108,000,000 | 3,930,000,000 | 1,925,000,000 | 574,000,000 | 2,033,000,000 | 816,000,000 | 2,138,000,000 | 943,000,000 | 2,000,000 | 2,437,000,000 | 1,236,000,000 | 336,000,000 | ||||||||||||||||||||||||||||||
cash flow from (used in) investing activities: | ||||||||||||||||||||||||||||||||||||||||||||
acquisitions of property and equipment | ||||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses and technologies, net of cash acquired | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from business dispositions | 48,000,000 | 48,000,000 | 5,442,000,000 | 5,471,000,000 | ||||||||||||||||||||||||||||||||||||||||
proceeds from the sale of mylan n.v. shares | 1,977,000,000 | 1,924,000,000 | 1,685,000,000 | 2,290,000,000 | ||||||||||||||||||||||||||||||||||||||||
sales (purchases) of other investment securities | ||||||||||||||||||||||||||||||||||||||||||||
net cash (used in) investing activities | ||||||||||||||||||||||||||||||||||||||||||||
cash flow from (used in) financing activities: | ||||||||||||||||||||||||||||||||||||||||||||
net borrowings (repayments) of short-term debt and other | 22,000,000 | 140,000,000 | ||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt | 4,011,000,000 | |||||||||||||||||||||||||||||||||||||||||||
repayments of long-term debt | ||||||||||||||||||||||||||||||||||||||||||||
payment of debt issuance costs | ||||||||||||||||||||||||||||||||||||||||||||
payment of contingent consideration | ||||||||||||||||||||||||||||||||||||||||||||
purchases of common shares | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from stock options exercised | 244,000,000 | 170,000,000 | 137,000,000 | 275,000,000 | 186,000,000 | 129,000,000 | ||||||||||||||||||||||||||||||||||||||
dividends paid | ||||||||||||||||||||||||||||||||||||||||||||
net cash (used in) financing activities | ||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | 35,000,000 | 97,000,000 | 73,000,000 | 65,000,000 | ||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of year | 9,407,000,000 | 9,407,000,000 | 9,407,000,000 | 18,620,000,000 | 18,620,000,000 | 18,620,000,000 | 5,001,000,000 | 5,001,000,000 | 5,001,000,000 | 4,063,000,000 | 4,063,000,000 | 4,063,000,000 | 3,475,000,000 | 3,475,000,000 | 3,475,000,000 | |||||||||||||||||||||||||||||
cash and cash equivalents, end of period | 7,369,000,000 | 3,065,000,000 | 3,857,000,000 | 11,012,000,000 | 9,675,000,000 | 8,706,000,000 | 2,500,000,000 | 2,578,000,000 | 3,334,000,000 | 3,132,000,000 | 4,048,000,000 | 3,226,000,000 | 3,613,000,000 | 3,570,000,000 | 2,060,000,000 | |||||||||||||||||||||||||||||
trade receivables, less allowances of 319 in 2018 and 294 in 2017 | 5,192,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2018: 1,969,575,366; 2017: 1,965,908,188 | 23,317,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2018: 215,256,082; 2017: 222,305,719 | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 321 in 2018 and 294 in 2017 | 5,356,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2018: 1,969,331,007; 2017: 1,965,908,188 | 23,223,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost - shares: 2018: 216,143,241; 2017: 222,305,719 | ||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile earnings to net cash from operating activities - | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from business disposition | 5,472,000,000 | 25,000,000 | 25,000,000 | 25,000,000 | 230,000,000 | 230,000,000 | 230,000,000 | |||||||||||||||||||||||||||||||||||||
sales (purchases) of investment securities | 446,000,000 | 3,358,000,000 | 1,119,000,000 | |||||||||||||||||||||||||||||||||||||||||
net cash from investing activities | 226,000,000 | 37,000,000 | 633,000,000 | |||||||||||||||||||||||||||||||||||||||||
net proceeds (repayments of) short-term debt and other | 6,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 279 in 2017 and 250 in 2016 | 4,800,000,000 | |||||||||||||||||||||||||||||||||||||||||||
current liabilities held for disposition | 597,000,000 | 361,000,000 | 360,000,000 | 356,000,000 | 292,000,000 | 301,000,000 | 721,000,000 | 242,000,000 | 169,000,000 | |||||||||||||||||||||||||||||||||||
non-current liabilities held for disposition | 60,000,000 | 96,000,000 | 1,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2017: 1,964,324,771; 2016: 1,707,475,455 | 23,118,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2017: 223,724,084; 2016: 234,606,250 | ||||||||||||||||||||||||||||||||||||||||||||
impact of currency devaluation | 481,000,000 | 477,000,000 | 477,000,000 | |||||||||||||||||||||||||||||||||||||||||
mylan n.v. equity investment adjustment | 947,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net (repayments of) short-term debt and other | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 265 in 2017 and 250 in 2016 | 4,633,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2017: 1,962,732,172; 2016: 1,707,475,455 | 23,012,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2017: 225,288,908; 2016: 234,606,250 | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 263 in 2017 and 250 in 2016 | 4,510,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2017: 1,960,925,194; 2016: 1,707,475,455 | 22,886,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost - shares: 2017: 225,653,140; 2016: 234,606,250 | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 284 in 2016 and 337 in 2015 | 3,320,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2016: 1,706,957,661; 2015: 1,702,017,390 | 12,939,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2016: 234,648,138; 2015: 229,352,338 | ||||||||||||||||||||||||||||||||||||||||||||
gain on sale of discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||
gain on sale of mylan n.v. shares | ||||||||||||||||||||||||||||||||||||||||||||
net (repayments of) proceeds from issuance of short-term debt and other | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from the issuance of long-term debt | 2,485,000,000 | 2,485,000,000 | 2,485,000,000 | |||||||||||||||||||||||||||||||||||||||||
proceeds from stock options exercised, including income tax benefit | 206,000,000 | 130,000,000 | 87,000,000 | 263,000,000 | 213,000,000 | 156,000,000 | 290,000,000 | 226,000,000 | 170,000,000 | |||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 347 in 2016 and 337 in 2015 | 3,567,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2016: 1,705,266,590; 2015: 1,702,017,390 | 12,835,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2016: 235,271,175; 2015: 229,352,338 | ||||||||||||||||||||||||||||||||||||||||||||
gain on sale of mylan shares | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from the sale of mylan shares | 2,290,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net cash (used in) from investing activities | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 350 in 2016 and 337 in 2015 | 3,430,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2016: 1,704,495,344; 2015: 1,702,017,390 | 12,744,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost - shares: 2016: 235,343,311; 2015: 229,352,338 | ||||||||||||||||||||||||||||||||||||||||||||
net cash (used in) from operating activities | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 358 in 2015 and 310 in 2014 | 3,460,000,000 | |||||||||||||||||||||||||||||||||||||||||||
prepaid expenses, deferred income taxes, and other receivables | 3,523,000,000 | 3,573,000,000 | 3,859,000,000 | 4,173,000,000 | 4,065,000,000 | 3,977,000,000 | 4,164,602,000 | 4,067,462,000 | ||||||||||||||||||||||||||||||||||||
common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2015: 1,700,525,346; 2014: 1,694,929,949 | 12,641,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2015: 208,805,455; 2014: 186,894,515 | ||||||||||||||||||||||||||||||||||||||||||||
amortization of intangibles | 458,000,000 | 307,000,000 | 156,000,000 | 464,000,000 | 335,000,000 | 174,000,000 | ||||||||||||||||||||||||||||||||||||||
(purchases) sales of other investment securities | ||||||||||||||||||||||||||||||||||||||||||||
net (repayments of ) proceeds from issuance of short-term debt and other | ||||||||||||||||||||||||||||||||||||||||||||
contingent and other consideration payments related to business acquisitions | ||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 138,000,000 | 95,000,000 | ||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 362 in 2015 and 310 in 2014 | 3,553,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2015: 1,699,703,688; 2014: 1,694,929,949 | 12,566,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost - shares: 2015: 209,262,223; 2014: 186,894,515 | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 317 in 2015 and 310 in 2014 | 3,481,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2015: 1,698,124,396; 2014: 1,694,929,949 | 12,462,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost - shares: 2015: 209,367,078; 2014: 186,894,515 | ||||||||||||||||||||||||||||||||||||||||||||
purchases of investment securities | ||||||||||||||||||||||||||||||||||||||||||||
net (repayments of) proceeds from short-term debt and other | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 332 in 2014 and 312 in 2013 | 3,618,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2014: 1,692,708,693; 2013: 1,685,827,096 | 12,207,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost - shares: 2014: 186,918,107; 2013: 137,728,810 | ||||||||||||||||||||||||||||||||||||||||||||
acquisitions of business and technology | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of short-term debt and other | 1,269,000,000 | 872,000,000 | 1,213,000,000 | |||||||||||||||||||||||||||||||||||||||||
transfer of cash and cash equivalents to abbvie inc. | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 354 in 2014 and 312 in 2013 | 4,056,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2014: 1,691,263,815; 2013: 1,685,827,096 | 12,126,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost - shares: 2014: 187,564,782; 2013: 137,728,810 | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 324 in 2014 and 312 in 2013 | 3,883,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized - 2,400,000,000 shares | ||||||||||||||||||||||||||||||||||||||||||||
issued at stated capital amount - shares: 2014: 1,689,594,829; 2013: 1,685,827,096 | 12,032,000,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost - shares: 2014: 187,656,291; 2013: 137,728,810 | ||||||||||||||||||||||||||||||||||||||||||||
investments, primarily time deposits and certificates of deposit | 31,806,000 | 51,076,000 | 255,253,000 | |||||||||||||||||||||||||||||||||||||||||
restricted funds, primarily u.s. treasury bills | 1,871,807,000 | 1,870,936,000 | 1,870,000,000 | |||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 330,469 in 2010 and 311,546 in 2009 | 6,248,908,000 | |||||||||||||||||||||||||||||||||||||||||||
prepaid expenses, deferred income taxes and other receivables | 4,167,996,000 | |||||||||||||||||||||||||||||||||||||||||||
salaries, wages and commissions and dividends payable | 1,693,496,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount - shares: 2010: 1,618,549,245; 2009: 1,612,683,987 | 8,624,344,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost — shares: 2010: 72,733,280; 2009: 61,516,398 | ||||||||||||||||||||||||||||||||||||||||||||
total equity | 21,482,724,000 | 19,994,634,000 | 21,012,340,000 | |||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 304,348 in 2010 and 311,546 in 2009 | 6,338,350,000 | |||||||||||||||||||||||||||||||||||||||||||
salaries, dividends payable, and other accruals | 6,298,586,000 | 6,301,954,000 | ||||||||||||||||||||||||||||||||||||||||||
preferred shares, one dollar par value authorized - 1,000,000 shares, none issued | ||||||||||||||||||||||||||||||||||||||||||||
issued at stated capital amount - | ||||||||||||||||||||||||||||||||||||||||||||
shares: 2010: 1,617,202,849; 2009: 1,612,683,987 | 8,504,865,000 | |||||||||||||||||||||||||||||||||||||||||||
common shares held in treasury, at cost - | ||||||||||||||||||||||||||||||||||||||||||||
shares: 2010: 73,174,127; 2009: 61,516,398 | ||||||||||||||||||||||||||||||||||||||||||||
trade receivables, less allowances of 315,873 in 2010 and 311,546 in 2009 | 6,520,222,000 | |||||||||||||||||||||||||||||||||||||||||||
shares: 2010: 1,616,801,616; 2009: 1,612,683,987 | 8,413,595,000 | |||||||||||||||||||||||||||||||||||||||||||
shares: 2010: 73,236,557; 2009: 61,516,398 |
We provide you with 20 years of balance sheets for Abbott Laboratories stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Abbott Laboratories. Explore the full financial landscape of Abbott Laboratories stock with our expertly curated balance sheets.
The information provided in this report about Abbott Laboratories stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.